Additionally, 75% of the patients undergoing treatment with gemcitabine plus albumin-bound paclitaxel did not develop CIPN by day 84. Peripheral neuropathy is a common adverse effect of neurotoxic ...
It often responds initially to chemotherapy but is the most common breast cancer to recur. When it recurs, triple-negative breast cancer portrays chemotherapy resistance, making it less responsive and ...
Gorgas, President and CEO of Artelo Biosciences. “Starting with ART26.12, our promising Fatty Acid Binding Protein 5 (FABP5) inhibitor drug candidate, we received FDA clearance to begin trials in ...
Topical treatments may help ease chemotherapy-induced peripheral neuropathy, but more research is needed. Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients ...
The Princess of Wales attended the Festival of Remembrance, her first royal family event since announcing she had completed chemotherapy in a video on Sept. 9 Janine Henni is a Royals Staff Writer ...